GI
BMRN icon

Gradient Investments’s BioMarin Pharmaceuticals BMRN Stock Holding History

Gradient Investments’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-80
Closed -$6.59K – 413
2024
Q2 		$6.59K Hold
80
– – ﹤0.01% 808
2024
Q1 		$6.99K Sell
80
-8
-9% -$716 ﹤0.01% 681
2023
Q4 		$8.48K Hold
88
– – ﹤0.01% 873
2023
Q3 		$7.79K Hold
88
– – ﹤0.01% 852
2023
Q2 		$7.63K Buy
88
+8
+10% +$753 ﹤0.01% 863
2023
Q1 		$7.78K Hold
80
– – ﹤0.01% 862
2022
Q4 		$8.28K Hold
80
– – ﹤0.01% 847
2022
Q3 		$7K Hold
80
– – ﹤0.01% 868
2022
Q2 		$7K Hold
80
– – ﹤0.01% 831
2022
Q1 		$6K Hold
80
– – ﹤0.01% 854
2021
Q4 		$7K Hold
80
– – ﹤0.01% 862
2021
Q3 		$6K Sell
80
-33
-29% -$2.6K ﹤0.01% 849
2021
Q2 		$9K Sell
113
-19
-14% -$1.51K ﹤0.01% 774
2021
Q1 		$10K Sell
132
-56,157
-100% -$4.59M ﹤0.01% 755
2020
Q4 		$4.28M Sell
56,289
-621
-1% -$49.2K 0.18% 117
2020
Q3 		$4.33M Buy
56,910
+9,898
+21% +$1M 0.18% 117
2020
Q2 		$5.8M Buy
47,012
+833
+2% +$82.8K 0.26% 93
2020
Q1 		$3.9M Buy
46,179
+4,008
+10% +$345K 0.21% 99
2019
Q4 		$3.57M Buy
42,171
+4,702
+13% +$355K 0.16% 103
2019
Q3 		$2.52M Buy
37,469
+8,361
+29% +$644K 0.12% 116
2019
Q2 		$2.49M Buy
29,108
+26,297
+936% +$2.25M 0.13% 108
2019
Q1 		$250K Buy
+2,811
New +$261K 0.02% 235
2018
Q3 		– Sell
-300
Closed -$28K – 981
2018
Q2 		$28K Buy
+300
New +$26.3K ﹤0.01% 424

Other funds holding BMRN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return

Gradient Investments's BMRN Position: Q3 2024 in Review

Gradient Investments sold out of BioMarin Pharmaceuticals (BMRN) in Q3 2024, closing a stake of 80 shares — an estimated $6.59K sold.

Gradient Investments first reported a position in BMRN in Q2 2018 and held it in 23 quarters. The position peaked at $5.8M in Q2 2020. 553 funds tracked by Wall St. Rank hold BMRN as of Q3 2024.

  • Gradient Investments reported no remaining BioMarin Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • Gradient Investments sold 80 BioMarin Pharmaceuticals shares in Q3 2024, an estimated $6.59K.
  • Gradient Investments first reported a position in BioMarin Pharmaceuticals in Q2 2018 and held it in 23 quarters.
  • Gradient Investments's BioMarin Pharmaceuticals position peaked at $5.8M in Q2 2020.
  • 553 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q3 2024.

Based on Gradient Investments's 13F filing for Q3 2024, filed 15 Oct 2024.